期刊文献+

冠心病患者中非高密度脂蛋白胆固醇和动脉粥样硬化指数水平分析 被引量:23

Non-high-density Lipoprotein Cholesterol Level and Atherosclerotic Index Analysis in Patients with Coronary Heart Disease
下载PDF
导出
摘要 比较非高密度脂蛋白胆固醇(non-HDL-C)和动脉粥样硬化指数(AI)水平在不同临床类型冠心病患者中的差异,分析其在冠心病中的价值。结果表明,急性冠脉综合症患者non-HDL-C和AI水平高于慢性稳定型冠心病患者;non-HDL-C和AI水平可能成为评价冠心病病情严重程度的一个有效指标。
出处 《中国医科大学学报》 CAS CSCD 北大核心 2014年第1期84-86,共3页 Journal of China Medical University
  • 相关文献

参考文献16

  • 1Di Angelantonio E,Sanvar N,Perry P. Major lipids,apolipoproteins,and risk of vascular disease[J].{H}JAMA:the Journal of the American Medical Association,2009,(5):1993-2000.
  • 2Expert Panel on Detection,Evaluation and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection,Evaluation,And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel Ⅲ)[J].{H}JAMA:the Journal of the American Medical Association,2001,(19):2486-2497.
  • 3Study of the Effectiveness Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group,Armitage J,Bowman L. Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction:a double-blind randomized trial[J].{H}LANCET,2010,(9753):1658-1669.
  • 4Hozawa A,Folsom AR,Sharrett AR. Does the impact of smoking on coronary heart disease differ by low-density lipoprotein cholesterol level?:the Atherosclerosis Risk in Communities (ARIC)Study[J].Citc J,2006,(9):1105-1110.
  • 5C holeterol Treatment Trialists' (CTT) Collaboration,Baigent C,Blackwell L. Efficacy and safety of more intensive lowering of LDL cholesterol:a meta-analysis of data from 170,000 participants in 26 randomized trials[J].{H}LANCET,2010,(9753):1670-1681.
  • 6Hsia J,MacFadyen G,Monyak J. Cardiovascular event reduction and adverse events among subjects attaining low-density lipoprotein cholesterol 《50 mg/dl with rosuvastatin:the JUPITER trial (Justification for the Use of Statins in Prevention:an Intervention Trial Evaluating Rosuvastatin)[J].{H}Journal of the America College of Cardiology,2011,(16):1666-1675.
  • 7Nicholls SJ,Ballantyne CM,Barter PJ. Effect of two intensive statin regimensv on progression of coronary disease[J].{H}New England Journal of Medicine,2011,(5):2078-2087.
  • 8Ballantyne CM,Andrews TC,Hsia JA. Correlation of non-highdensity lipoprotein cholesterol with apolipoprotein B:effect of 5-hydroxymethylglutaryl coenzyme A reductase inhibitors on non-highdensity lipoprotein cholesterol levels[J].{H}American Journal of Cardiology,2001,(86):265-269.
  • 9Robinson JG,Wang S,Smith B J. Meta-analysis of the relationship between non-high-density lipoprotein cholesterol reduction and coronary heart disease risk[J].{H}Am Coll Cardiol J,2009,(18):316-322.
  • 10中国成人血脂异常防治指南制订联合委员会.中国成人血脂异常防治南[J]{H}中华心血管病杂志,2007(10):390-419.

二级参考文献6

  • 1贾志梅,齐国先,庞雪蜂,时景璞,王海龙,李辉,董卫,付凌雨,康辉,宫伟,李继光,王文利,姜玉山.彰武县农村人群冠心病患病率及影响因素调查[J].中国公共卫生,2004,20(8):972-973. 被引量:12
  • 2李佳进,孙兆青,郑黎强,冯亮,张新忠,张心刚,刘双双,许长禄,赵芬芬,董光辉,胡大一,孙英贤.辽宁省阜新县农村冠心病流行病学特征及危险因素调查[J].山西医科大学学报,2007,38(2):139-142. 被引量:8
  • 3Sousa RM,Ferri CP,Acosta D,et al. The contribution of chronic dis eases to the prevalence of dependence among older people in Laatin America, China and India: a 10/66 Dementia Research Group popu- lation-based survey [J ]. BMC Geriatr, 2010, 10( 53 ) : 1-12.
  • 4Dong G, Sun Z, Zheng L, et al. Prevalence, awareness, treatment, and control of hypertension in rural adults from Liaoning Province, north- east China [ J ]. Hypertens Res, 2007,30 ( 10 ) : 951-958.
  • 5Sidorenkov O, Nilssen O, Grjibovski AM. Metabolic: syndrome in Rus sian adults:associated factors and mortality from cardiovascular dis eases and all causes [J]. BMC Public Health,2010, 10 ( 1 ):582 -591.
  • 6] Ilali E ,Taraghi Z. Comparison of risk factors of CHD in the men and women with MI [J]. Pak J Biol Sci,2010, 13(7 ):344-347.

共引文献83

同被引文献194

引证文献23

二级引证文献220

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部